- Angel Investment Opportunity
Investment Opportunity to
Redefine Digital Mental
Healthcare at Scale
Healthcare at Scale
Blissiree retrains the brain during sleep to produce lasting mental health improvements
— addressing anxiety, depression, PTSD, stress, and burnout
at their root, not just easing symptoms.
Minimum Investment
AUD $12,500
Minimum shares
50,000
Stage
- The Investment Opportunity
Why Invest in Blissiree
Blissiree solves a growing problem: global mental healthcare. Millions of people are seeking real, lasting change, yet most digital wellness tools focus on short-term symptom relief rather than addressing the underlying drivers of mental distress.
Discover the Blissiree Opportunity
Blissiree is positioned to capture 1+% of the current US$8.5 billion digital mental healthcare app market via its effective, evidence-based approach.
Sleep-Based Intervention
Blissiree works during sleep when the brain is most receptive to change, bypassing conscious resistance.
Neuroplasticity Science
Grounded in decades of clinical research into the brain's ability to reorganize and form new neural pathways.
Lasting Results
Addresses root causes of mental distress rather than offering temporary symptom relief.
Non-Pharmaceutical
A natural alternative for those seeking drug-free mental wellness solutions.
- Traction & Proof
Blissiree is Not a Concept
It is a validated platform with real traction and published medical research studies.
- 2 Peer-Reviewed Papers Published
- Award-Winning Platform
- Strong User Engagement
- Success Stories
Real People. Real Transformation.
Blissiree users include individuals living with chronic anxiety, depression, PTSD, stress, and burnout — as well as professionals seeking long-term emotional resilience and success.
Police Officer's Battle with PTSD
Battling Cancer & Mental Illness
How Blissiree has helped me recover from migraines
- The Science Behind Blissiree
Backed by Research
Blissiree is grounded in decades of clinical studies into triggering neuroplasticity — the brain’s ability to reorganize itself by forming new neural connections. Through masked positive auditory stimuli delivered during sleep, Blissiree engages the unconscious brain to help retrain emotional responses.
Neuroplasticity Research
Grounded in decades of clinical studies into triggering the brain's ability to reorganize itself.
Published Studies
Statistically significant improvements across anxiety, depression, stress, PTSD, and self-esteem.
Sleep Integration
Masked positive auditory stimuli during sleep when resistance is lowest and integration is highest.
About the app
Blissiree is a science-based mental health app built on decades of biomedical and neuroscience research. Developed using carefully structured audio scripts, Blissiree works with the brain during rest and sleep—when it is most receptive to lasting change.
Blissiree can be used alongside traditional therapy or medication—or as a standalone solution. It’s convenient, stigma-free, and accessible, working while you sleep with no appointments or barriers to care. More than a wellness trend, Blissiree is a scalable, research-driven digital mental healthcare solution designed for today’s global mental health crisis.
- Why We're Raising Capital Now
Accelerating Scale Through Technology
Blissiree has proven its scientific foundation, early traction, and user demand. This angel round is focused on transforming Blissiree into a deeply personalized, intelligent digital mental healthcare app and then marketing it heavily.
UI/UX Modernization
Premium, intuitive user experience
AI Chatbot Companion
Personalized support and guidance
AI-Driven Personalization
Content that adapts to your progress
Multi-Channel Engagement
Push notifications and WhatsApp
Instant App Experiences
App Clips and Instant Apps
- Who This Opportunity Is For
Join a Select Group of Founding Investors
This round is intentionally limited to 10-12 investors to maintain alignment and a clean cap table.
With the current US$20 monthly subscription, 10,000 subscribers generate US$200,000 in monthly revenue. 4.5 million subscribers (similar to a popular meditation app) generate US$90 million in monthly revenue.
Friends & Family
Those who believe in the mission
Early Believers
Evidence-based mental health advocates
Angel Investors
Healthtech and impact focused
Impact Seekers
Meaningful impact + growth potential
AUD $12,500
10-12
Stage
Early Revenue
- Express Interest
Become a Blissiree Shareholder
If you are interested in investing a minimum of USD $8,000 (AUD $12,500) to support the rebuilding and scaling of this platform, express interest to request further information.
For questions, contact:
peter@blissiree.com